Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

LinkedIn adds a pharma 'influencer'

Pfizer CEO Ian Read joins the likes of Bill Gates and Richard Branson in writing for the social network
LinkedIn Pfizer Ian Read

LinkedIn this week added the first pharma voice to its Influencer articles with a post by Pfizer CEO Ian Read.  

The articles have been contributed from business leaders such as Bill Gates and Richard Branson since October 2012 as part of moves towards publishing that have also seen it launch the LinkedIn Today news service.  

Read's 'You gain respect in drops, but can lose it in gallons' takes aim at the importance of a pharma company's reputation and just one day after publication had amassed more than 8,500 views.  

In terms of engagement the article is doing well too, having so far attracted more than 1,200 shares and 66 comments on LinkedIn, not to mention 45 tweets and 112 Facebook 'likes'.  

LinkedIn influencers

The Pfizer CEO's debut as an Influencer, one of more than 50 names added, including the CEOs of Nissan and Morgan Stanley, comes as LinkedIn starts opening up its publishing platform to its rank and file members.  

Members will be able to share long-form posts to their LinkedIn profile and, in a Facebook-like move, they can be followed by LinkedIn members with which they are not connected.

21st February 2014

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Creative Medical Research

Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making...

Latest intelligence

Enabling market access through outcomes-based pricing
Outcomes-based pricing is a potential solution to create a link between product price and real-world outcomes, while at the same time facilitating patient access to new and innovative medicines....
Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...

Infographics